Dow Jones Top Financial Services Headlines at 7 AM ET: Bags of Cash From Drug Cartels Flood Teller Windows at U.S. Banks | Allianz ... Bags of Cash From Drug Cartels Flood Teller Windows at U.S. Banks ...

Diversified healthcare company CVS Health (NYSE:CVS) announced better-than-expected revenue in Q1 CY2025, with sales up 7% ...

CVS Health reported strong first-quarter results that exceeded Wall Street’s expectations. The company’s revenue ...

Despite lower-than-expected first-quarter revenues and a guidance cut for 2025, NVO stock price rose post its earnings ...

Overall, Wall Street has a Strong Buy consensus rating on Eli Lilly stock based on 18 Buys and one Sell recommendation. The average LLY stock price target of $981 implies about 26.6% upside potential.

Sales are booming for Lilly's tirzepatide products, Mounjaro and Zepbound. The company's market share for incretin analogs ...

Activist investor Glenview Capital is reducing its stake in healthcare giant CVS Health following its first-quarter earnings ...

We expect disappointing results in the first quarter will be balanced by higher-than-anticipated growth in the second half.

Payer profits fell in 2024 as Americans, especially older ones, utilized more medical care. But efforts to resuscitate ...

Drugmaker Novo Nordisk expects Wegovy weight-loss drug sales in the United States to start to recover once a ban on compound ...

Following the sell-off, Lilly trades at a forward price-to-earnings (P/E) of 37 times 2025 analyst estimates, with a price-to ...

Three years since COVID-19 abated, UnitedHealth Group, CVS Health and other insurers are still feeling the hangover, ...